More meds doubling in price

Prices have ballooned by 100 percent or more for a growing number of drugs, according to a new study. In fact, the number of branded meds whose prices have grown that much could double this year from four years ago. In 2007, the average wholesale price of 26 brand-name meds jumped 100 percent or more in a single price increase, up from 15 in 2004. In the first half of 2008, 17 made that list.

Many of the price increases have come on drugs that treat rare but serious conditions. For example, Questcor Pharmaceuticals boosted the price of Acthar, which treats spasms in babies, to $23,000 from $1,650 a vial.

- read the story in USA Today

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.